Goldman Sachs
IMPL

Goldman Sachs’s Impel Pharmaceuticals Inc. Common Stock IMPL Stock Holding History

Goldman Sachs’s Portfolio IMPL Stock Details IMPL Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
2022
Q3 		$55K Sell
2022
Q2 		$133K Buy
2022
Q1 		$82K Buy
2021
Q4 		$92K Buy